Advertisement

NYMX

Nymox Pharmaceutical Corporation

Healthcare

Set alert

Price alert · NYMX

All alert types
0.20 0.00 0.00%
As of Jul 6, 2023
0.1999 Day range 0.1999

52-week range unavailable

Open
0.22
Prev close
0.1999
Mkt cap
18.25M
Vol
881.57K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1999
High
0.1999
Forward P/E
0.00
Beta
0.65
Short ratio
59.73
Inst. own
1.12%
Dividend
0.00
Ex-div date
Earnings
May 12, 2023
50-d avg
0.385079
200-d avg
0.385119
1y target
10.25

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NYMX has not been loaded yet. Try again in a moment.

Ownership

Held by insiders 45.03%
Held by institutions 1.12%
Float held by institutions 2.03%
Institutions 39

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Blackrock Inc.0.15%135,61227.12KMar 30, 2023
Cetera Advisor Networks LLC0.13%118,90023.78KMar 30, 2023
Morgan Stanley0.11%98,68619.74KMar 30, 2023
Simplicity Solutions, LLC0.09%80,00016.00KMar 30, 2023
Bleakley Financial Group, LLC 0.09%80,00016.00KMar 30, 2023
Renaissance Technologies, LLC0.08%69,38113.88KMar 30, 2023

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
iShares Micro Cap ETF0.12%112,23822.45KFeb 27, 2023
Fidelity NASDAQ Composite Index Fund0.06%50,67810.13KFeb 27, 2023
EQ Advisors Trust-1290 VT Micro Cap Port0.01%9,3181.86KDec 30, 2022
Master Investment Portfolio-Diversified Equity Master Portfolio0.01%5,6851.14KDec 30, 2022
NYMX insiders
InsiderRelationLatest transactionDateShares held
AVERBACK PAULChief Executive OfficerSaleOct 28, 201821,643,900
DANIELSEN ERIKChief Financial OfficerPurchaseDec 20, 201820,900
LANHAM RANDALL J ESQ.General CounselPurchaseOct 25, 2018152,900
ROBINSON JAMES GEORGEDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseApr 26, 20234,782,060
Advertisement